127 related articles for article (PubMed ID: 3470543)
1. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
3. Immunological role of vitamin A and its related substances in prevention of cancer.
Tomita Y
Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
5. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
[TBL] [Abstract][Full Text] [Related]
6. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of astaxanthin and its mode of action.
Jyonouchi H; Sun S; Iijima K; Gross MD
Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
10. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
[TBL] [Abstract][Full Text] [Related]
11. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
[TBL] [Abstract][Full Text] [Related]
12. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
13. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
Henderson LA; Ciavarra R; Riblet R; Forman J
J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
[TBL] [Abstract][Full Text] [Related]
14. [The beta-carotene stimulation of cellular immunity reactions in mice].
Abronina IF; Ramanauskaĭte RIu; Andreĭchuk TN; Rytenko AN; Korostelev SA
Biull Eksp Biol Med; 1993 Sep; 116(9):295-8. PubMed ID: 8118006
[TBL] [Abstract][Full Text] [Related]
15. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
16. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
Gomi K; Morimoto M; Nomoto K
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
[TBL] [Abstract][Full Text] [Related]
17. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).
Harada M; Seta K; Ito O; Tamada K; Li T; Terao H; Takenoyama M; Kimura G; Nomoto K
Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):687-703. PubMed ID: 8537606
[TBL] [Abstract][Full Text] [Related]
18. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo.
Chew BP; Park JS; Wong MW; Wong TS
Anticancer Res; 1999; 19(3A):1849-53. PubMed ID: 10470126
[TBL] [Abstract][Full Text] [Related]
20. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Townsend SE; Su FW; Atherton JM; Allison JP
Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
